Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Rang in Aktien
#4949
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Aktienkurs
$2.47
Marktkapitalisierung
$2.95B
Veränderung (1 Tag)
0.18%
Veränderung (1 Jahr)
-14.53%
Land
CN
Handel Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Anzahl der ausstehenden Aktien zum June 2026: 1.17B
Laut den neuesten Finanzberichten und dem Aktienkurs von Jilin Aodong Pharmaceutical Group Co., Ltd. beträgt die aktuelle Anzahl der ausstehenden Aktien 1.17B. Am Ende von December 2023 hatte das Unternehmen 1.13B ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Jilin Aodong Pharmaceutical Group Co., Ltd. (000623) von 2000 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 1.17B | -0.40% |
| 2024 | 1.18B | 4.59% |
| 2023 | 1.13B | -0.81% |
| 2022 | 1.13B | -0.41% |
| 2021 | 1.14B | -1.63% |
| 2020 | 1.16B | -0.40% |
| 2019 | 1.16B | 0.02% |
| 2018 | 1.16B | 0.00% |
| 2017 | 1.16B | 1.31% |
| 2016 | 1.15B | -1.28% |
| 2015 | 1.16B | 0.17% |
| 2014 | 1.16B | -0.49% |
| 2013 | 1.17B | -0.06% |
| 2012 | 1.17B | 0.56% |
| 2011 | 1.16B | -0.12% |
| 2010 | 1.16B | -0.20% |
| 2009 | 1.16B | -0.04% |
| 2008 | 1.16B | 0.05% |
| 2007 | 1.16B | 0.20% |
| 2006 | 1.16B | -0.20% |
| 2005 | 1.16B | 0.00% |
| 2004 | 1.16B | 0.00% |
| 2003 | 1.16B | 0.00% |
| 2002 | 1.16B | 0.00% |
| 2001 | 1.16B | 0.00% |
| 2000 | 1.16B | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 104.65% |
IN
|
